CBT
TMO icon

Central Bank & Trust’s Thermo Fisher Scientific TMO Stock Holding History

Central Bank & Trust’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$909K Buy
1,813
+4
+0.2% +$1.92K 0.13% 110
2026
Q1 		$889K Sell
1,809
-197
-10% -$107K 0.14% 109
2025
Q4 		$1.16M Sell
2,006
-83
-4% -$46.9K 0.18% 101
2025
Q3 		$1.01M Buy
2,089
+144
+7% +$67K 0.16% 109
2025
Q2 		$789K Sell
1,945
-49
-2% -$20.5K 0.13% 115
2025
Q1 		$992K Buy
1,994
+61
+3% +$33K 0.17% 101
2024
Q4 		$1.01M Sell
1,933
-53
-3% -$29.1K 0.15% 94
2024
Q3 		$1.23M Sell
1,986
-7
-0.4% -$4.14K 0.17% 90
2024
Q2 		$1.1M Sell
1,993
-247
-11% -$142K 0.15% 95
2024
Q1 		$1.3M Sell
2,240
-602
-21% -$338K 0.19% 86
2023
Q4 		$1.51M Sell
2,842
-724
-20% -$350K 0.23% 83
2023
Q3 		$1.8M Sell
3,566
-5
-0.1% -$2.66K 0.31% 65
2023
Q2 		$1.86M Buy
3,571
+62
+2% +$33.5K 0.32% 61
2023
Q1 		$2.02M Buy
3,509
+54
+2% +$30.4K 0.36% 64
2022
Q4 		$1.9M Buy
3,455
+75
+2% +$39.7K 0.36% 69
2022
Q3 		$1.71M Buy
3,380
+600
+22% +$336K 0.37% 64
2022
Q2 		$1.51M Buy
2,780
+501
+22% +$276K 0.31% 68
2022
Q1 		$1.35M Sell
2,279
-125
-5% -$71.8K 0.21% 81
2021
Q4 		$1.6M Sell
2,404
-11
-0.5% -$6.87K 0.25% 78
2021
Q3 		$1.38M Sell
2,415
-44
-2% -$24.1K 0.23% 84
2021
Q2 		$1.24M Sell
2,459
-22
-0.9% -$10.4K 0.2% 84
2021
Q1 		$1.13M Sell
2,481
-265
-10% -$126K 0.19% 90
2020
Q4 		$1.28M Sell
2,746
-14
-0.5% -$6.56K 0.22% 85
2020
Q3 		$1.22M Sell
2,760
-181
-6% -$74.8K 0.23% 85
2020
Q2 		$1.07M Buy
2,941
+8
+0.3% +$2.68K 0.21% 84
2020
Q1 		$832K Sell
2,933
-79
-3% -$24.9K 0.2% 87
2019
Q4 		$978K Buy
3,012
+312
+12% +$94.6K 0.19% 93
2019
Q3 		$786K Buy
2,700
+325
+14% +$93.1K 0.17% 94
2019
Q2 		$697K Buy
2,375
+195
+9% +$53.7K 0.16% 94
2019
Q1 		$597K Buy
2,180
+845
+63% +$210K 0.13% 102
2018
Q4 		$299K Buy
1,335
+920
+222% +$216K 0.08% 116
2018
Q3 		$101K Buy
415
+13
+3% +$2.99K 0.02% 155
2018
Q2 		$83K Buy
402
+66
+20% +$14K 0.02% 156
2018
Q1 		$69K Sell
336
-78
-19% -$16.4K 0.02% 161
2017
Q4 		$79K Buy
414
+52
+14% +$9.96K 0.02% 171
2017
Q3 		$68K Hold
362
– – 0.02% 169
2017
Q2 		$63K Hold
362
– – 0.02% 171
2017
Q1 		$56K Buy
362
+175
+94% +$26.7K 0.01% 182
2016
Q4 		$26K Hold
187
– – 0.01% 222
2016
Q3 		$30K Sell
187
-46
-20% -$7.09K 0.01% 205
2016
Q2 		$34K Hold
233
– – 0.01% 197
2016
Q1 		$33K Buy
233
+73
+46% +$9.78K 0.01% 201
2015
Q4 		$23K Hold
160
– – 0.01% 231
2015
Q3 		$20K Hold
160
– – 0.01% 251
2015
Q2 		$21K Hold
160
– – 0.01% 236
2015
Q1 		$21K Hold
160
– – 0.01% 237
2014
Q4 		$20K Hold
160
– – 0.01% 245
2014
Q3 		$19K Hold
160
– – 0.01% 221
2014
Q2 		$18K Hold
160
– – 0.01% 214
2014
Q1 		$19K Hold
160
– – 0.01% 212
2013
Q4 		$18K Hold
160
– – 0.01% 214
2013
Q3 		$15K Hold
160
– – 0.01% 225
2013
Q2 		$14K Buy
+160
New +$13.3K 0.01% 233

Other funds holding TMO

Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
LT
Lindsell Train London, United Kingdom $2.63B AUM 2.97% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
CF
Canoe Financial Calgary, Alberta, Canada $8.07B AUM 25.47% 1-Year Est. Return
SP
Sarasin & Partners London, United Kingdom $8.54B AUM 9.6% 1-Year Est. Return
DLA
Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return
PL
Perpetual Ltd Sydney, New South Wales, Australia $7B AUM 19.75% 1-Year Est. Return
HPC
HM Payson & Co Portland, Maine $7.54B AUM 31.34% 1-Year Est. Return

Central Bank & Trust's TMO Position: Q2 2026 in Review

Central Bank & Trust increased its Thermo Fisher Scientific (TMO) stake by 0.22% in Q2 2026, buying an estimated $1.92K and bringing the position to 1,813 shares worth $909K. The position accounts for 0.13% of the portfolio, ranked #110.

Central Bank & Trust first reported a position in TMO in Q2 2013 and has held it in 53 quarters since. The position peaked at $2.02M in Q1 2023. 438 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Central Bank & Trust held 1,813 shares of Thermo Fisher Scientific worth $909K as of Q2 2026.
  • Central Bank & Trust bought 4 Thermo Fisher Scientific shares in Q2 2026, an estimated $1.92K.
  • Thermo Fisher Scientific made up 0.13% of Central Bank & Trust's portfolio in Q2 2026, its #110 holding.
  • Central Bank & Trust first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 53 quarters since.
  • Central Bank & Trust's Thermo Fisher Scientific position peaked at $2.02M in Q1 2023.
  • 438 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Central Bank & Trust's 13F filing for Q2 2026, filed 17 Jul 2026.